An open label pilot study in mild to moderate AD patients to assess the effects of treatment with ECHS AD pulsed electromagnetic treatment device on disease progression. Enrolled patients will receive active devices. They will treat themselves at home three times a day for 15 minutes over 120 days. Primary end points are the The Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Exam. Participants will be followed-up for 9 months post-treatment.
Age range
50 Years – 100 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog)
Timeframe: Change between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days
Mini-Mental Status Exam (MMSE)
Timeframe: Change between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days
Global Deterioration questionnaire
Timeframe: Change between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days
Quality of Life Scale
Timeframe: Change between day 0, and 30, 60, 90, 120, 150, 240, 310, 400 days